Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway

Biochemistry, Genetics and Molecular Biology

• NOX4 100%
• Species 90%
• Glucose 80%
• Resveratrol 80%
• AMP-activated Protein Kinase 60%
• Fibroblast 40%
• Cell Activation 30%
• Db/Db Mouse 20%
• Regulatory Mechanism 20%
• Myofibroblast 10%
• Cell Proliferation 10%
• Electric Potential 10%
• Oxidase 10%
• Small Interfering RNA 10%
• Nicotinamide Adenine Dinucleotide Phosphate 10%

Medicine and Dentistry

• Glucose 80%
• Resveratrol 80%
• Hydroxymethylglutaryl Coenzyme A Reductase Kinase 60%
• Fibroblast 40%
• Idiopathic Pulmonary Fibrosis 30%
• Kidney Fibrosis 30%
• Cell Activation 30%
• Diabetic Nephropathy 20%
• Mitogen Activated Protein Kinase 3 20%
• Regulatory Mechanism 20%
• Pathogenesis 10%
• Cell Proliferation 10%
• Small Interfering RNA 10%
• Combination Therapy 10%
• Diabetes Mellitus 10%
• Therapeutic Agent 10%
• Oxidoreductase 10%
• Nicotinamide Adenine Dinucleotide Phosphate 10%
• Cells 10%
• Therapeutic Procedure 10%
• Myofibroblast 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Reactive Oxygen Metabolite 90%
• Glucose 80%
• Resveratrol 80%
• Hydroxymethylglutaryl Coenzyme A Reductase Kinase 60%
• Kidney Fibrosis 30%
• Fibrosing Alveolitis 30%
• Mitogen Activated Protein Kinase 3 20%
• Db/Db Mouse 20%
• Diabetic Nephropathy 20%
• Oxidoreductase 10%
• Pathogenesis 10%
• Diabetes Mellitus 10%
• Nicotinamide Adenine Dinucleotide Phosphate 10%
• Small Interfering RNA 10%